The Use of Vascular Endothelial Growth Factor Inhibitors in Patients with Proliferative Diabetic Retinopathy
Diabetic retinopathy (DR) have been taking a leading position among retinal disorders, causing a persistent and significant decrease in visual functions. The base of the disease is a retinal vascular microangiopathy, which induces a tissue ischemia and excessive production of vascular endothelial gr...
| Hlavní autoři: | , |
|---|---|
| Médium: | Článek |
| Jazyk: | Russian |
| Vydáno: |
Ophthalmology Publishing Group
2022-07-01
|
| Edice: | Oftalʹmologiâ |
| Témata: | |
| On-line přístup: | https://www.ophthalmojournal.com/opht/article/view/1867 |